Rezafungin Acetate is a medication used in this clinical trial to help prevent or treat fungal infections in children. Fungal infections can be serious, especially in people with weakened immune systems. This medication is given through an IV, which means it is delivered directly into the bloodstream. The trial is focused on understanding how the body processes this medication and ensuring it is safe and well-tolerated by children from birth up to 18 years old. By studying this, researchers hope to confirm that rezafungin acetate can be an effective option for protecting against or treating fungal infections in young patients.

Fungal Infections – Fungal infections are caused by fungi, which are microorganisms that can invade and grow in various parts of the body. These infections can affect the skin, nails, lungs, or other organs, depending on the type of fungus involved. The progression of a fungal infection often begins with the fungus entering the body through inhalation, a cut, or other means. Once inside, the fungus can multiply and spread, leading to symptoms such as redness, itching, or more severe systemic effects. The severity and progression of the infection depend on the type of fungus and the individual’s immune response. Some fungal infections may remain localized, while others can become invasive, affecting multiple body systems.